arrow
G

Giovanna Travi

Asst Grande Ospedale Metropolitano Niguarda
H指数:16
被引数:962

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A randomized clinical trial to compare moxiFloxAcin veRsus aziTHromycin for the trEatment of MycoplaSma geniTalium: the FARTHEST Study

一项随机临床试验比较莫西沙星与阿奇霉素治疗生殖支原体的效果:FARTHEST研究

2026-05-170
PRE
Patterns and Correlates of Initiation of Long-Acting Injectable Cabotegravir for Preexposure Prophylaxis: A Case-Control Analysis

长效注射用卡博特gravir作为暴露前预防的启动模式和相关性:一项病例对照分析

2026-03-013
PRE
Use of a molecular syndromic panel for the etiological diagnosis of bloodstream infections in critically ill patients: impact on clinical outcomes and antimicrobial use from a multicenter, prospective study

利用分子综合征面板对危重患者血流感染进行病因学诊断:一项多中心、前瞻性研究对临床结局和抗菌药物使用的影响

2026-01-010
OAAI
Use of a molecular syndromic panel for the etiological diagnosis of ventilator-associated bacterial pneumonia: impact on clinical outcomes and antibiotic use from a multicenter, prospective study

使用分子综合征检测板进行呼吸机相关细菌性肺炎的病因学诊断:一项多中心、前瞻性研究对临床结局和抗生素使用的影响

2025-10-030
OAAI
Use of isavuconazole in critically ill patients in intensive care units: a prospective, observational, multicentre, cohort study

Giacobbe, D.R.; Bartalucci, C.; Bavastro, M. ICU危重患者中使用伊沙康唑的前瞻性、观察性、多中心、队列研究。JAC Antimicrob. Resist. 2025, 7, dlaf177. [Google Scholar] [CrossRef]

2025-10-010
PRE
Effectiveness and Tolerability of Dual Antiviral Therapy in Immunosuppressed Patients with Protracted SARS-CoV-2 Infection

免疫抑制患者中双重抗病毒疗法的效果与耐受性

2025-08-240
PRE
Outbreak of Vancomycin-Resistant Enterococcus in a NICU: Insights into Molecular Detection and Infection Control

万古霉素耐药肠球菌在NICU中的暴发:分子检测和感染控制的见解

2025-04-040
OA
Effectiveness and Tolerability of Dual Antiviral Therapy in Immunosuppressed Patients with Protracted SARS-CoV-2 Infection

长期SARS-CoV-2感染的免疫抑制患者双重抗病毒治疗的有效性和耐受性

2025-02-260
OAAI
Cerebral Infectious Opportunistic Lesions in a Patient with Acute Myeloid Leukaemia: The Challenge of Diagnosis and Clinical Management
2024-04-240
OAAI
SARS-CoV-2 RNA in plasma samples of COVID-19 affected individuals: a cross-sectional proof-of-concept study
2021-02-1729
OAAI